Inventor · disambiguated record
Anuk Das
Also filed as: DAS ANUK
4 granted patents·9 pending applications·36 citations·filing 2003–2013
74Inventor score
Top patents by PatentIndex Score
13 records- 0186US8153583B2Toll like receptor 3 antagonists, methods and usesCARTON JILL M·Filed 2005·Granted Apr 10, 2012·22 cites·9 claims
- 0282US7371825B2Anti-MCP-1 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2005·Granted May 13, 2008·5 cites·11 claims
- 0374US8114964B2Anti-MCP-1 antibodies, compositions, methods and usesDAS ANUK·Filed 2007·Granted Feb 14, 2012·3 cites·5 claims
- 0473US8277809B2CXCL13 antagonists and their use for the treatment of inflammatory diseasesBUGELSKI PETER·Filed 2007·Granted Oct 2, 2012·6 cites·15 claims
- 0551US2005025822A1Method of pulmonary administration of an agentFiled 2004·Application pending·0 cites
- 0651US2005232923A1Methods and compositions for treating MCP-1 related pathologiesYAN LI·Filed 2004·Application pending·0 cites
- 0750US2005244410A1Toll-like receptor 9 effector agents and uses thereofBASSIRI ASHLYN·Filed 2004·Application pending·0 cites
- 0848US2004185450A1MCP-1 mutant proteins, antibodies, compositions, methods and usesFiled 2003·Application pending·0 cites
- 0946US2010183620A1Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2BHAWE KAUMUDI·Filed 2009·Application pending·0 cites
- 1044US2014255388A1Toll like receptor 3 antagonists, methods and usesCARTON JILL M·Filed 2013·Application pending·0 cites
- 1142US2012189643A1Toll Like Receptor 3 Antagonists, Methods and UsesCARTON JILL M·Filed 2012·Application pending·0 cites
- 1241US2010254992A1Anti-mcp-1 antibodies, compositions, methods and usesDAS ANUK·Filed 2008·Application pending·0 cites
- 1338US2010074886A1Ccr2 antagonists for treatment of fibrosisDAS ANUK·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anuk Das files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →